What is Kenvue Interest Expense?
Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Kenvue's interest expense for the
three
months ended in Mar. 2024 was $ -95 Mil.
Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was $-452 Mil.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Kenvue's Operating Income for the
three
months ended in Mar. 2024 was $ 661 Mil. Kenvue's Interest Expense for the
three
months ended in Mar. 2024 was $ -95 Mil.
Kenvue's Interest Coverage for the quarter that ended in Mar. 2024 was 6.96.
The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Kenvue Interest Expense Calculation
Interest Expense is the amount reported by a company or individual as an expense for borrowed money.
Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-452 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kenvue (NYSE:KVUE) Interest Expense Explanation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.
Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Kenvue's Interest Expense for the
three
months ended in Mar. 2024 was $-95 Mil. Its
Operating Income
for the
three
months ended in Mar. 2024 was $661 Mil. And its Long-Term Debt & Capital Lease Obligation for the
three
months ended in Mar. 2024 was $7,131 Mil.
Kenvue's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The higher the ratio, the stronger the company's financial strength is.
Kenvue (Kenvue) Business Description
Traded in Other Exchanges
Address
199 Grandview Road, Skillman, NJ, USA, 08558
Kenvue is the world's largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio includes a wide array of some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and ever-changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.
Executives
| Allison Richard E Jr |
director |
30 FRANK LLOYD WRIGHT DR, ANN ARBOR MI 48105 |
| Seemantini Godbole |
director |
1000 LOWE'S BOULEVARD, MOORESVILLE NC 28117 |
| Bing Xie |
officer: Group President, Asia Pacific |
199 GRANDVIEW ROAD, SKILLMAN NJ 08558 |
| Donna Lorenson |
officer: Chief Corp Affairs Officer |
199 GRANDVIEW ROAD, SKILLMAN NJ 08558 |
| Matthew Orlando |
officer: General Counsel |
199 GRANDVIEW ROAD, SKILLMAN NJ 08558 |
| Luani Alvarado |
officer: Chief People Officer |
199 GRANDVIEW ROAD, SKILLMAN NJ 08558 |
| Jan Meurer |
officer: Chief Growth Officer |
199 GRANDVIEW ROAD, SKILLMAN NJ 08558 |
| Carlton Lawson |
officer: Group President, EMEA |
199 GRANDVIEW ROAD, SKILLMAN NJ 08558 |
| Caroline Tillett |
officer: Chief Scientific Officer |
199 GRANDVIEW ROAD, SKILLMAN NJ 08558 |
| Bernardo Tavares |
officer: Chief Tech & Data Officer |
199 GRANDVIEW ROAD, SKILLMAN NJ 08558 |
| Tamara Franklin |
director |
107 STONE CLIFF ROAD, PRINCETON NJ 08540 |
| Betsy D Holden |
director |
DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277 |
| Kathy Widmer |
officer: Group President, NALA |
C/O ELIZABETH ARDEN, INC., 2400 S.W. 145 AVENUE, MIRAMAR FL 33027 |
| Michael E Sneed |
director |
JOHNSON & JOHNSON, ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK NJ 08933 |
| Joseph J Wolk |
director |
JOHNSON & JOHNSON, ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK NJ 08933 |
Kenvue (Kenvue) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
KVUE has been successfully added to your 